5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
5:00 pm
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue...
5:00 pm
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy...
5:00 pm
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
12:00 am
NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular...
12:00 am
The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants fund small businesses and research organizations whose work benefits the public. The annual SBIR & STTR Omnibus Solicitation, released by the Department of Health...
12:00 am
The NIH will fund up to $300,000 to projects that support testing new therapeutic uses for experimental drugs across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for...
12:00 am
NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for...
5:00 pm
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue...
5:00 pm
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy...
5:00 pm
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
May
24
Wed
DEADLINE: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Application
May 24 @ 5:00 pm
DEADLINE: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Application

The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience or translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research  that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral mechanisms that begin in childhood and adolescence.

Learn more and submit your application here.

Source: NIH

Jun
5
Mon
DEADLINE: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research Application
Jun 5 @ 5:00 pm
DEADLINE: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research Application

The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.

Learn more and submit your application here.

Source: NIH

DEADLINE: Potential Effects of Metformin on Aging and Age-Related Conditions Application
Jun 5 @ 5:00 pm
DEADLINE: Potential Effects of Metformin on Aging and Age-Related Conditions Application

NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy human life span.  This includes identification of specific populations particularly likely to benefit from treatment, and/or obtaining information on metformin’s effects that would be useful in identifying novel molecular targets.

Learn more and submit your application.

Source: NIH

Jun
12
Mon
DEADLINE: Research Career Enhancement Award to Advance Therapy Development for Alzheimer’s (K18) Applications
Jun 12 @ 5:00 pm
DEADLINE: Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18) Applications

The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer’s Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD research.

Learn more and submit your application.

Source: National Institute on Aging

Jul
31
Mon
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Jul 31 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Aug
15
Tue
DEADLINE: Discovering Pediatric New Therapeutic Uses for Existing Molecules Letter of Intent
Aug 15 all-day
DEADLINE: Discovering Pediatric New Therapeutic Uses for Existing Molecules Letter of Intent

NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for drugs from pharmaceutical company partners. Strong applications will include scientific evidence that your drug repurposing will have a positive impact on the disease/condition.

Learn more and submit your letter of intent here.

Source: NIH NCATS

Aug
26
Sat
DEADLINE: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent
Aug 26 @ 5:00 pm
DEADLINE: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent

The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or assessing molecular and cellular features of cancer biology. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Learn more and submit your Letter of Intent.

Source: National Cancer Institute

DEADLINE: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent
Aug 26 @ 5:00 pm
DEADLINE: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent

The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular analysis technologies. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Learn more and submit your Letter of Intent.

Source: National Cancer Institute

Sep
5
Tue
DEADLINE: SBIR & STTR Omnibus Solicitation Grant Applications
Sep 5 all-day
DEADLINE: SBIR & STTR Omnibus Solicitation Grant Applications

The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants fund small businesses and research organizations whose work benefits the public. The annual SBIR & STTR Omnibus Solicitation, released by the Department of Health and Human Services, accept investigator-initiated grant applications across a broad range of research areas. Eligible small businesses should have the capabilities and technology to contribute to the mission of the awarding NIH Institute or Center.

Learn more and apply here.

Source: NIH

Sep
15
Fri
DEADLINE: Discovering New Therapeutic Uses for Existing Molecules Applications
Sep 15 all-day
DEADLINE: Discovering New Therapeutic Uses for Existing Molecules Applications

The NIH will fund up to $300,000 to projects that support testing new therapeutic uses for experimental drugs across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for Assets from pharmaceutical company partners. Strong applications will include scientific evidence that modulation of an Assets target should have a positive impact on the disease/condition. Submit a pre-application first.

Learn more and apply here.

Source: NIH